CN104491747A - Traditional Chinese medicine tablets for treating pelvic inflammatory disease and preparation method thereof - Google Patents

Traditional Chinese medicine tablets for treating pelvic inflammatory disease and preparation method thereof Download PDF

Info

Publication number
CN104491747A
CN104491747A CN201510004568.5A CN201510004568A CN104491747A CN 104491747 A CN104491747 A CN 104491747A CN 201510004568 A CN201510004568 A CN 201510004568A CN 104491747 A CN104491747 A CN 104491747A
Authority
CN
China
Prior art keywords
parts
radix
herba
inflammatory disease
pelvic inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510004568.5A
Other languages
Chinese (zh)
Inventor
唐萍
周恩昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510004568.5A priority Critical patent/CN104491747A/en
Publication of CN104491747A publication Critical patent/CN104491747A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533—Leonurus (motherwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/758—Zanthoxylum, e.g. pricklyash
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses traditional Chinese medicine tablets for treating pelvic inflammatory disease, relates to the field of medicines for treating pelvic inflammatory disease and is mainly used for solving the problems of the existing medicines for treating pelvic inflammatory disease that the side effects are serious and not the disease but symptoms are treated. The prepared tablets comprise the following active ingredients in parts by mass: 5-30 parts of herba portulacae, 15-30 parts of herba taraxaci, 15-30 parts of herba leonuri, 10-25 parts of herba patriniae, 10-30 parts of herba scutellariae barbatae, 15-30 parts of radix astragali, 5-20 parts of cassia twig, 5-25 parts of fructus liquidambaris, 10-25 parts of semen plantaginis, 5-25 parts of radix curcumae, 10-25 parts of radix puerariae, 5-25 parts of akebia stem, 15-35 parts of peach seed, 5-25 parts of cactus, 10-25 parts of radix zanthoxyli, 5-15 parts of rhizoma cyperi, 5-25 parts of Chinese angelica, 10-25 parts of radix paeoniae alba, 5-25 parts of curcuma zedoary and 15-30 parts of radix glycyrrhizae. Clinical practice indicates that the total effective rate of the traditional Chinese medicine tablets in treating pelvic inflammatory disease is over 98% and toxic and side effects are avoided.

Description

A kind of Chinese medicinal tablet for the treatment of pelvic inflammatory disease and preparation method thereof
Technical field
The present invention relates to treatment pelvic inflammatory disease technical field of pharmaceuticals, specifically a kind of Chinese medicinal tablet for the treatment of pelvic inflammatory disease and preparation method thereof.
Background technology
Pelvic inflammatory disease and pelvic inflammation refer to female pelvic cavity genitals, periuterine connective tissue and pelvic peritoneal inflammation.Chronic pelvic inflammation often acute stages treated is not thoroughly delayed, and its disease time is long, and the state of an illness is more obstinate.Antibacterial retrograde infection, by uterus, fallopian tube and arrive pelvic cavity.Its symptom mainly lower abdominal pain, heating, vaginal secretions increases, and suffers from abdominal pain as persistence, movable or sexual intercourse postemphasis.Shiver with cold, high heat, headache, inappetence can be had if be in a bad way.
The traditional Chinese medical science sums up pelvic inflammatory disease because being due to the long-term virtual loss of QI and blood, innate deficiency, health preserving accidentally, caused by the unclean or overstrain of vaginal orifice.Current doctor trained in Western medicine mainly takes the Therapeutic Method of the anti-inflammation and sterilizations such as transfusion, medicine-feeding, not only can not effect a radical cure, and on the contrary due to life-time service antibiotics, causes producing drug resistance etc., thus further increases treatment difficulty, use exists certain drawback.Pelvic inflammatory disease recurrence probability is high, and mainly Western medicine sanatory while, cannot improve the environment in patient body, brings certain limitation to the treatment of pelvic inflammatory disease.
Summary of the invention
The medicine that the object of the invention is to solve existing treatment pelvic inflammatory disease has the problem that certain side effect can not improve the environment in patient body, and a kind of Chinese medicinal tablet for the treatment of pelvic inflammatory disease provided.
The technical solution used in the present invention is: a kind of Chinese medicinal tablet for the treatment of pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 5 ~ 30 parts, Herba Taraxaci 15 ~ 30 parts, Herba Leonuri 15 ~ 30 parts, Herba Patriniae 10 ~ 25 parts, Herba Scutellariae Barbatae 10 ~ 30 parts, the Radix Astragali 15 ~ 30 parts, Ramulus Cinnamomi 5 ~ 20 parts, Fructus Liquidambaris 5 ~ 25 parts, Semen Plantaginis 10 ~ 25 parts, Radix Curcumae 5 ~ 25 parts, Radix Puerariae 10 ~ 25 parts, Caulis Akebiae 5 ~ 25 parts, 15 ~ 35 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 5 ~ 25 parts, Radix Zanthoxyli 10 ~ 25 parts, Rhizoma Cyperi 5 ~ 15 parts, Radix Angelicae Sinensis 5 ~ 25 parts, the Radix Paeoniae Alba 10 ~ 25 parts, Rhizoma Curcumae 5 ~ 25 parts, 15 ~ 30 parts, Radix Glycyrrhizae.
Further, a kind of Chinese medicinal tablet for the treatment of pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 10 ~ 25 parts, Herba Taraxaci 20 ~ 25 parts, Herba Leonuri 20 ~ 25 parts, Herba Patriniae 15 ~ 20 parts, Herba Scutellariae Barbatae 15 ~ 25 parts, the Radix Astragali 20 ~ 25 parts, Ramulus Cinnamomi 10 ~ 15 parts, Fructus Liquidambaris 10 ~ 20 parts, Semen Plantaginis 15 ~ 20 parts, Radix Curcumae 10 ~ 20 parts, Radix Puerariae 15 ~ 20 parts, Caulis Akebiae 10 ~ 20 parts, 20 ~ 30 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 10 ~ 20 parts, Radix Zanthoxyli 15 ~ 20 parts, Rhizoma Cyperi 8 ~ 13 parts, Radix Angelicae Sinensis 10 ~ 20 parts, the Radix Paeoniae Alba 15 ~ 20 parts, Rhizoma Curcumae 10 ~ 20 parts, 20 ~ 25 parts, Radix Glycyrrhizae.
Further, treat a Chinese medicinal tablet for pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 17 parts, Herba Taraxaci 22 parts, Herba Leonuri 23 parts, Herba Patriniae 17 parts, Herba Scutellariae Barbatae 20 parts, the Radix Astragali 22 parts, Ramulus Cinnamomi 13 parts, Fructus Liquidambaris 15 parts, Semen Plantaginis 17 parts, Radix Curcumae 15 parts, Radix Puerariae 18 parts, Caulis Akebiae 15 parts, 25 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 15 parts, Radix Zanthoxyli 17 parts, Rhizoma Cyperi 10 parts, Radix Angelicae Sinensis 16 parts, the Radix Paeoniae Alba 18 parts, Rhizoma Curcumae 14 parts, 23 parts, Radix Glycyrrhizae.
The present invention also comprises a kind of preparation method for the treatment of the Chinese medicinal tablet of pelvic inflammatory disease, described preparation method concrete steps are as follows: after each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.13 ~ 1.14, extractum and the starch or the Icing Sugar Homogeneous phase mixing that account for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine, every sheet 0.8 gram.
Instructions of taking: being grown up every day 1,3 days is a course for the treatment of.
Medical material effect of the present invention is resolved as follows:
Herba Portulacae sour in the mouth, cold in nature, effect is clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body, antiinflammatory, quench the thirst, diuresis.Herba Taraxaci bitter in the mouth, cold in nature, effect is heat-clearing and toxic substances removing, diuresis eliminating stagnation, and primary treatment controls pyretic toxicity, carbuncle, skin infection, abscess of internal organ, conjunctival congestion and swelling pain, damp and hot, the puckery pain of jaundice, dribbling urination, furuncle swelling toxin.Herba Leonuri acrid in the mouth, hardship, property micro-enter, effect is for invigorating blood circulation, and blood stasis dispelling, regulating menstruation, disappear water, as long as treatment menoxenia, vaginal bleeding during pregnancy is had difficult labour, and retention of placenta, puerperal blood faints, abdominal pain due to blood stasis, metrorrhagia and metrostaxis, hematuria, rushes down blood, carbuncle skin infection.Herba Patriniae is cool in nature, acrid in the mouth, hardship, and effect is heat-clearing and toxic substances removing, evacuation of pus of eliminating the phlegm, primary treatment acute appendicitis, lung abscess, dysentery, and postnatal blood stasis is suffered from abdominal pain, carbuncle furuncle.Herba Scutellariae Barbatae acrid in the mouth, hardship, cold in nature, effect is heat-clearing and toxic substances removing, blood stasis dispelling diuresis, and for furuncle swelling toxin, laryngopharynx swelling and pain, falls and flutter the pain of injury, edema, jaundice, snake bite and insect sting.Radix Astragali sweet in the mouth, tepor, effect is benefiting QI for strengthening the superficies, detoxification granulation promoting, and the primary treatment deficiency of vital energy is weak, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy edema, and carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency dull yellowish colored skin, interior-heat is quenched one's thirst.Ramulus Cinnamomi acrid in the mouth, sweet, warm in nature, effect is relieving the exterior syndrome by diaphoresis, dispersing cold for relieving pain, activating YANG and prormoting functioning of QI, if treatment anemofrigid cold, all pain diseases of congealing cold with blood stasis, phlegm retention, syndrome of water-retention, cardiopalmus.Fructus Liquidambaris bitter in the mouth is put down, and effect is dispelling, collateral-activating, and diuretic stimulates the menstrual flow, as long as arthralgia, and numbness contracture, edema distension, the few amenorrhea of breast.Semen Plantaginis sweet in the mouth, cold in nature, effect is that clearing away heat and promoting diuresis is treating stranguria, eliminating dampness by diuresis antidiarrheal, and improving eyesight, eliminates the phlegm, and is mainly used in the puckery pain of pyretic stranguria, edema distension, diarrhea due to summer heat and dampness, conjunctival congestion and swelling pain, phlegm-heat cough.Radix Curcumae acrid in the mouth is bitter, and cool in nature, effect is promoting QI circulation for relieving depression, removing heat from blood removing blood stasis with potent drugs.Control all pains of breast abdomen side of body rib, lose the heart demented, calentura coma, spit blood, epistaxis, hematuria, stranguria with blood, women's vicarious menstruation, jaundice.Radix Puerariae sweet in the mouth, pungent, cool in nature, effect is expelling pathogenic factors from muscles for reducing heat, rash, promoting the production of body fluid to quench thirst, yang invigorating antidiarrheal, and for exterior syndrome heating, stiff nape and back, measles without adequate eruption, calentura is thirsty, and the deficiency of YIN is quenched one's thirst, diarrhea of heat type hematodiarrhoea, diarrhea due to hypofunction of the spleen.Caulis Akebiae bitter in the mouth, cold in nature, effect is inducing diuresis for treating stranguria syndrome, and clear away heart-fire relieving restlessness, stimulating milk secretion of stimulating the menstrual flow, primary treatment stranguria, edema, vexed dark coloured urine, aphtha of the mouth and tongue, and amenorrhea breast is few, damp and hot arthralgia pain.The bitter sweet property of Semen Persicae is put down, and effect is removing blood stasis blood stasis expelling, moisturizes laxation, controls amenorrhea, lump in the abdomen, calentura blood-retention, migratory arthralgia, malaria, traumatic injury, swelling and pain due to blood stasis, the dry constipation of blood.Radix et Caulis Opuntiae Dillenii bitter in the mouth is cold in nature, and effect is promoting flow of QI and blood, heat-clearing and toxic substances removing, treatment heart peratodynia, mass in the abdomen, dysentery, hemorrhoidal bleeding, cough, laryngalgia, lung abscess, acute mastitis, furuncle, burn, snakebite.Radix Zanthoxyli bitter in the mouth, pungent, property are put down.Effect is promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling, dispelling wind and removing obstruction in the collateral, is mainly used in traumatic injury, rheumatic arthralgia that qi depression to blood stasis causes.The micro-hardship of Rhizoma Cyperi acrid in the mouth is sweet, property put down, function for resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving, primary treatment mammary swelling educate, menoxenia, abdominal pain during menstruation, bleeding not during menses, frequent fetal movement.Radix Angelicae Sinensis sweet in the mouth, warm in nature, effect for enriching blood, invigorating blood circulation, menstruction regulating and pain relieving, moisturize laxation, all cards of primary treatment blood deficiency, menoxenia, amenorrhea, dysmenorrhea, lump in the abdomen knot are poly-, metrorrhagia, asthenia cold abdominalgia, flaccidity syndrome and arthralgia syndrome, numbness of the skin, dryness of the intestine dyschezia, weight, ulcer sores, injury from falling down after bloody dysentery.Radix Paeoniae Alba bitter in the mouth, acid, cold nature, effect is suppressing the hyperactive liver pain relieving, nourishing blood for regulating menstruation, astringing YIN to stop sweating, is mainly used in headache dizzy, hypochondriac pain, stomachache, limb pain twin, blood deficiency and yellow complexion, menoxenia, spontaneous perspiration, night sweat.Rhizoma Curcumae bitter in the mouth, warm in nature, effect is promoting QI circulation for relieving depression, removing blood stasis with potent drugs, pain relieving, as long as treatment coagulation of QI-blood, trusted subordinate's distending pain, lump in the abdomen, gathers, and dyspepsia does not disappear, women's blood stasis amenorrhea, traumatic injury.Radix Glycyrrhizae sweet in the mouth, property are flat, and it contains number of chemical composition, and effect is replenishing QI to invigorate the spleen, expelling phlegm for arresting cough, heat-clearing and toxic substances removing, relieving spasm to stop pain.
The present invention has following beneficial effect: medicine of the present invention, Herba Portulacae clearing away heat-damp and promoting diuresis, Herba Taraxaci heat-clearing and toxic substances removing, Herba Leonuri blood circulation promoting and blood stasis dispelling, Herba Patriniae and Herba Scutellariae Barbatae heat-clearing and toxic substances removing, remove the mycovirus source of infection of pelvic inflammatory disease, Radix Astragali benefiting QI for strengthening the superficies, Ramulus Cinnamomi activating YANG and prormoting functioning of QI, Fructus Liquidambaris dispelling, collateral-activating, the puckery pain of Semen Plantaginis pyretic stranguria, Radix Curcumae removing heat from blood removing blood stasis with potent drugs, Radix Puerariae expelling pathogenic factors from muscles for reducing heat, Caulis Akebiae inducing diuresis for treating stranguria syndrome, dispersing cold for relieving pain, benefiting QI for strengthening the superficies, Semen Persicae removing blood stasis blood stasis expelling, Radix et Caulis Opuntiae Dillenii promoting flow of QI and blood, Radix Zanthoxyli promoting the circulation of QI to relieve pain, Rhizoma Cyperi menstruction regulating and pain relieving, Chinese angelica blood supplementing is invigorated blood circulation, Radix Paeoniae Alba nourishing blood for regulating menstruation, Rhizoma Curcumae promoting QI circulation for relieving depression, Radix Glycyrrhizae replenishing QI to invigorate the spleen, circulation of qi promoting intestinal stasis relieving, blood circulation promoting and blood stasis dispelling, treating both the principal and secondary aspects of a disease, and medical material is easy to get, each medical material all has no side effect, long-term taking also can not damage internal organs, medication is safer.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further elaborated.
Embodiment 1:
Treat a Chinese medicinal tablet for pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 5 parts, Herba Taraxaci 15 parts, Herba Leonuri 15 parts, Herba Patriniae 10 parts, Herba Scutellariae Barbatae 10 parts, the Radix Astragali 15 parts, Ramulus Cinnamomi 5 parts, Fructus Liquidambaris 5 parts, Semen Plantaginis 10 parts, Radix Curcumae 5 parts, Radix Puerariae 10 parts, Caulis Akebiae 5 parts, 15 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 5 parts, Radix Zanthoxyli 10 parts, Rhizoma Cyperi 5 parts, Radix Angelicae Sinensis 5 parts, the Radix Paeoniae Alba 10 parts, Rhizoma Curcumae 5 parts, 15 parts, Radix Glycyrrhizae.
After each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.13, extractum and the starch Homogeneous phase mixing accounting for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine.Be grown up every day 1, every sheet 0.8 gram 3 days is a course for the treatment of.
Embodiment 2:
Treat a Chinese medicinal tablet for pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 30 parts, Herba Taraxaci 30 parts, Herba Leonuri 30 parts, Herba Patriniae 25 parts, Herba Scutellariae Barbatae 30 parts, the Radix Astragali 30 parts, Ramulus Cinnamomi 20 parts, Fructus Liquidambaris 25 parts, Semen Plantaginis 25 parts, Radix Curcumae 25 parts, Radix Puerariae 25 parts, Caulis Akebiae 25 parts, 35 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 25 parts, Radix Zanthoxyli 25 parts, Rhizoma Cyperi 15 parts, Radix Angelicae Sinensis 25 parts, the Radix Paeoniae Alba 25 parts, Rhizoma Curcumae 25 parts, 30 parts, Radix Glycyrrhizae.
After each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.13, extractum and the Icing Sugar Homogeneous phase mixing accounting for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine.Be grown up every day 1, every sheet 0.8 gram 3 days is a course for the treatment of.
Embodiment 3:
Treat a Chinese medicinal tablet for pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 10 parts, Herba Taraxaci 20 parts, Herba Leonuri 20 parts, Herba Patriniae 15 parts, Herba Scutellariae Barbatae 15 parts, the Radix Astragali 20 parts, Ramulus Cinnamomi 10 parts, Fructus Liquidambaris 10 parts, Semen Plantaginis 15 parts, Radix Curcumae 10 parts, Radix Puerariae 15 parts, Caulis Akebiae 10 parts, 20 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 10 parts, Radix Zanthoxyli 15 parts, Rhizoma Cyperi 8 parts, Radix Angelicae Sinensis 10 parts, the Radix Paeoniae Alba 15 parts, Rhizoma Curcumae 10 parts, 20 parts, Radix Glycyrrhizae.
After each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.14, extractum and the starch Homogeneous phase mixing accounting for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine.Be grown up every day 1, every sheet 0.8 gram 3 days is a course for the treatment of.
Embodiment 4:
Treat a Chinese medicinal tablet for pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 25 parts, Herba Taraxaci 25 parts, Herba Leonuri 25 parts, Herba Patriniae 20 parts, Herba Scutellariae Barbatae 25 parts, the Radix Astragali 25 parts, Ramulus Cinnamomi 15 parts, Fructus Liquidambaris 20 parts, Semen Plantaginis 20 parts, Radix Curcumae 20 parts, Radix Puerariae 20 parts, Caulis Akebiae 20 parts, 30 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 20 parts, Radix Zanthoxyli 20 parts, Rhizoma Cyperi 13 parts, Radix Angelicae Sinensis 20 parts, the Radix Paeoniae Alba 20 parts, Rhizoma Curcumae 20 parts, 25 parts, Radix Glycyrrhizae.
After each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.14, extractum and the Icing Sugar Homogeneous phase mixing accounting for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine.Be grown up every day 1, every sheet 0.8 gram 3 days is a course for the treatment of.
Embodiment 5:
Treat a Chinese medicinal tablet for pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 17 parts, Herba Taraxaci 22 parts, Herba Leonuri 23 parts, Herba Patriniae 17 parts, Herba Scutellariae Barbatae 20 parts, the Radix Astragali 22 parts, Ramulus Cinnamomi 13 parts, Fructus Liquidambaris 15 parts, Semen Plantaginis 17 parts, Radix Curcumae 15 parts, Radix Puerariae 18 parts, Caulis Akebiae 15 parts, 25 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 15 parts, Radix Zanthoxyli 17 parts, Rhizoma Cyperi 10 parts, Radix Angelicae Sinensis 16 parts, the Radix Paeoniae Alba 18 parts, Rhizoma Curcumae 14 parts, 23 parts, Radix Glycyrrhizae.
After each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.13, extractum and the starch Homogeneous phase mixing accounting for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine.Be grown up every day 1, every sheet 0.8 gram 3 days is a course for the treatment of.
Embodiment 6:
Treat a Chinese medicinal tablet for pelvic inflammatory disease, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 9 parts, Herba Taraxaci 23 parts, Herba Leonuri 21 parts, Herba Patriniae 14 parts, Herba Scutellariae Barbatae 26 parts, the Radix Astragali 15 parts, Ramulus Cinnamomi 13 parts, Fructus Liquidambaris 20 parts, Semen Plantaginis 12 parts, Radix Curcumae 11 parts, Radix Puerariae 23 parts, Caulis Akebiae 15 parts, 27 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 17 parts, Radix Zanthoxyli 25 parts, Rhizoma Cyperi 5 parts, Radix Angelicae Sinensis 6 parts, the Radix Paeoniae Alba 13 parts, Rhizoma Curcumae 25 parts, 15 parts, Radix Glycyrrhizae.
After each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.13, extractum and the Icing Sugar Homogeneous phase mixing accounting for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine.Be grown up every day 1, every sheet 0.8 gram 3 days is a course for the treatment of.
Clinical data and case:
In order to show therapeutic effect of the present invention, system clinical observation treatment being carried out to 100 routine Patients with Pelvic Inflammatory Diseases, in the process of above-mentioned clinical observation, record being carried out to the medical history of above-mentioned patient, the state of an illness and curative effect.
Clinical therapeutic efficacy criterion is:
Cure: common sign stomachache occurs together heat, soreness of waist pain, menoxenia, leucorrhoea grow in quantity, urgent micturition, shiver with cold, whole disappearance such as high heat, headache, inappetence.
Take a turn for the better: subjective symptoms stomachache occur together heat, soreness of waist pain, menoxenia, leucorrhoea grow in quantity, urgent micturition, shiver with cold, high heat, have a headache, inappetence disappears substantially.
Invalid: symptom is not improved.
Therapeutic effect: the present invention treats through 100 routine pelvic inflammation patients, 89 example recoveries from illness, 9 examples take a turn for the better, and 2 examples are invalid, and total effective rate reaches 98%.
Model case:
Case 1: patient Wang, female, 29 years old, patient's stomachache occurred together heat, soreness of waist pain, menoxenia, leucorrhoea grow in quantity, urgent micturition, and after taking 2 courses for the treatment of of Chinese medicinal tablet of the present invention, symptom obviously alleviates, and continues to take 2 courses for the treatment of, and symptom disappears completely, follows up a case by regular visits to and does not recur half a year.
Case 2: patient Lee, female, 40 years old.Patient's stomachache occur together heat, soreness of waist pain, menoxenia, leucorrhoea grow in quantity, urgent micturition, shiver with cold, high heat, have a headache, inappetence, after taking 5 courses for the treatment of of Chinese medicinal tablet of the present invention, symptom disappears completely, follows up a case by regular visits to and does not recur for 1 year.
Case 3: patient Jiang, female, 33 years old.Patient's soreness of waist pain, menoxenia, leucorrhoea grow in quantity, urgent micturition, after taking 1 course for the treatment of of Chinese medicinal tablet of the present invention, symptom obviously alleviates, and after continuing to take 3 courses for the treatment of of Chinese medicinal tablet of the present invention, malaise symptoms disappears completely, follows up a case by regular visits to and does not recur for 1 year.

Claims (4)

1. treat the Chinese medicinal tablet of pelvic inflammatory disease for one kind, it is characterized in that, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 5 ~ 30 parts, Herba Taraxaci 15 ~ 30 parts, Herba Leonuri 15 ~ 30 parts, Herba Patriniae 10 ~ 25 parts, Herba Scutellariae Barbatae 10 ~ 30 parts, the Radix Astragali 15 ~ 30 parts, Ramulus Cinnamomi 5 ~ 20 parts, Fructus Liquidambaris 5 ~ 25 parts, Semen Plantaginis 10 ~ 25 parts, Radix Curcumae 5 ~ 25 parts, Radix Puerariae 10 ~ 25 parts, Caulis Akebiae 5 ~ 25 parts, 15 ~ 35 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 5 ~ 25 parts, Radix Zanthoxyli 10 ~ 25 parts, Rhizoma Cyperi 5 ~ 15 parts, Radix Angelicae Sinensis 5 ~ 25 parts, the Radix Paeoniae Alba 10 ~ 25 parts, Rhizoma Curcumae 5 ~ 25 parts, 15 ~ 30 parts, Radix Glycyrrhizae.
2. a kind of Chinese medicinal tablet for the treatment of pelvic inflammatory disease according to claim 1, it is characterized in that, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 10 ~ 25 parts, Herba Taraxaci 20 ~ 25 parts, Herba Leonuri 20 ~ 25 parts, Herba Patriniae 15 ~ 20 parts, Herba Scutellariae Barbatae 15 ~ 25 parts, the Radix Astragali 20 ~ 25 parts, Ramulus Cinnamomi 10 ~ 15 parts, Fructus Liquidambaris 10 ~ 20 parts, Semen Plantaginis 15 ~ 20 parts, Radix Curcumae 10 ~ 20 parts, Radix Puerariae 15 ~ 20 parts, Caulis Akebiae 10 ~ 20 parts, 20 ~ 30 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 10 ~ 20 parts, Radix Zanthoxyli 15 ~ 20 parts, Rhizoma Cyperi 8 ~ 13 parts, Radix Angelicae Sinensis 10 ~ 20 parts, the Radix Paeoniae Alba 15 ~ 20 parts, Rhizoma Curcumae 10 ~ 20 parts, 20 ~ 25 parts, Radix Glycyrrhizae.
3. a kind of Chinese medicinal tablet for the treatment of pelvic inflammatory disease according to claim 1, it is characterized in that, the crude drug mass fraction making the effective ingredient of tablet is: Herba Portulacae 17 parts, Herba Taraxaci 22 parts, Herba Leonuri 23 parts, Herba Patriniae 17 parts, Herba Scutellariae Barbatae 20 parts, the Radix Astragali 22 parts, Ramulus Cinnamomi 13 parts, Fructus Liquidambaris 15 parts, Semen Plantaginis 17 parts, Radix Curcumae 15 parts, Radix Puerariae 18 parts, Caulis Akebiae 15 parts, 25 parts, Semen Persicae, Radix et Caulis Opuntiae Dillenii 15 parts, Radix Zanthoxyli 17 parts, Rhizoma Cyperi 10 parts, Radix Angelicae Sinensis 16 parts, the Radix Paeoniae Alba 18 parts, Rhizoma Curcumae 14 parts, 23 parts, Radix Glycyrrhizae.
4. treat the preparation method of the Chinese medicinal tablet of pelvic inflammatory disease for one kind, it is characterized in that, described preparation method concrete steps are as follows: after each for Chinese medicine components in mass portion number ratio mixing, carry out micronizing, obtain superfine powder, in superfine powder, add the mass concentration accounting for medicine gross mass 8 times amount is the ethanol of 70%, then reflux, extract, 3 times, each 1 hour, merge extractive liquid, also cools 10min, again through 16 layers of filtered through gauze, filtrate concentrates at outer circulation concentrator, concentrated condition is: pressure 0.03Mpa, temperature 70 C, be concentrated into the extractum that relative density is 1.13 ~ 1.14, extractum and the starch or the Icing Sugar Homogeneous phase mixing that account for extractum gross mass 10%, cross 16 mesh sieves and make wet grain, grain will be wet in 50 DEG C of dryings, with 16 mesh sieve granulate, add the magnesium stearate accounting for medicine gross mass 1%, mixing, tablet is pressed into tablet machine.
CN201510004568.5A 2015-01-06 2015-01-06 Traditional Chinese medicine tablets for treating pelvic inflammatory disease and preparation method thereof Pending CN104491747A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510004568.5A CN104491747A (en) 2015-01-06 2015-01-06 Traditional Chinese medicine tablets for treating pelvic inflammatory disease and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510004568.5A CN104491747A (en) 2015-01-06 2015-01-06 Traditional Chinese medicine tablets for treating pelvic inflammatory disease and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104491747A true CN104491747A (en) 2015-04-08

Family

ID=52933261

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510004568.5A Pending CN104491747A (en) 2015-01-06 2015-01-06 Traditional Chinese medicine tablets for treating pelvic inflammatory disease and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104491747A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109248244A (en) * 2018-11-15 2019-01-22 泗水县人民医院 A kind of Chinese medicine and preparation method thereof for treating gynaecological imflammation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
张新成: "《很灵很灵的老偏方：老祖宗传下来的102个小偏方》", 31 October 2012, 辽宁科学技术出版社 *
李凤英等: "慢性盆腔炎的中医辨证、治法及用药规律文献研究", 《第九次全国中医妇科学术研讨会论文集》 *
辜翔等: "《女性病药膳食疗秘方.妇科篇》", 31 May 2004, 海天出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109248244A (en) * 2018-11-15 2019-01-22 泗水县人民医院 A kind of Chinese medicine and preparation method thereof for treating gynaecological imflammation

Similar Documents

Publication Publication Date Title
CN104740458A (en) Pruritus treating traditional Chinese medicine composition
CN105998334A (en) Application of traditional Chinese medicine composition in preparation of medicine for treating haemorrhoids
CN102512616B (en) Chinese medicinal anti-acne composition
CN103751691B (en) A kind of medicine for the treatment of eczema
CN104906465A (en) Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof
CN101618201B (en) Medicine for curing vulvar leukoplakia
CN104225486A (en) Traditional Chinese medicine for treating chronic cholecystitis
CN101569738A (en) Plaster for treating mastitis, hyperplasia of mammary glands, breast lumps, join thydrops, traumatic injury, preparation method and application thereof
CN103301337B (en) Traditional Chinese medicine for treating bovine puerperal fever
CN102727725B (en) Pharmaceutical composition for promoting healing of postoperative wound
CN104739941A (en) Traditional Chinese medicine preparation for treating kidney-Yang deficiency type aciesis and preparation method thereof
CN104547748A (en) Anti-acne drug and preparation method thereof
CN104013903A (en) Traditional Chinese medicine unguent for treating infantile eczema
CN103550708B (en) Chinese herbal compound for treating dysmenorrheal
CN104491747A (en) Traditional Chinese medicine tablets for treating pelvic inflammatory disease and preparation method thereof
CN104758701A (en) Medicament for nursing treatment of stomach stones after lithotripsy and preparation method of medicament
CN103845547A (en) Traditional Chinese medicine decoction for treating mumps
CN104758754A (en) Medicine for treating kidney qi deficiency benign prostate hyperplasia and preparation method thereof
CN104587202A (en) Traditional Chinese medicine ointment for treating eczema and preparation method traditional Chinese medicine ointment
CN104162026A (en) Traditional Chinese medicine composition treating hypertension and preparation method thereof
CN105663657A (en) Decoction medicine capable of effectively treating fire excess from yin deficiency and preparation method thereof
CN105434808A (en) Traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof
CN104922557A (en) Traditional Chinese medicine formula for treating haemorrhoids
CN105012620A (en) Traditional Chinese medicine composition for treating dysmenorrhea
CN104474147A (en) Traditional Chinese medicine for treating liver depression Qi stagnation type postpartum hypogalactia and preparation method of traditional Chinese medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150408

RJ01 Rejection of invention patent application after publication